MyFinsight
Home
Blog
About
Contact
Download
Download image
Gross proceeds from
private placement of...
$3,300K
Net proceeds from
exercise of warrants
$129K
Proceeds from sale of
assets
$335K
Net
(decrease)/increase in cash, cash...
-$3,285K
Net cash provided by
financing activities
$3,391K
Net cash provided by
investing activities
$335K
Canceled cashflow
$38K
Net
(decrease)/increase in cash, cash...
-$3,285K
Canceled cashflow
$3,726K
Change in fair value of
warrant liability
$3,161K
Stock-based compensation
expense
$1,023K
Prepaid expenses and
other current assets
-$665K
Amortization of operating
lease right-of-use...
$420K
Loss on operating
lease right-of-use...
$241K
Accounts payable
$220K
Depreciation and
amortization
$32K
Amortization of finance lease
right-of-use assets
$4K
Transaction costs paid
pursuant to private...
$29K
Payments of capital lease
liability principal
$9K
Net cash used in
operating activities
-$7,011K
Canceled cashflow
$5,766K
Net loss
-$10,345K
Accrued expenses and
other liabilities
-$1,353K
Operating lease
liabilities
-$1,042K
Net gain on disposal
of assets
$37K
Back
Back
Cash Flow
source: myfinsight.com
Matinas BioPharma Holdings, Inc. (MTNB)
Matinas BioPharma Holdings, Inc. (MTNB)